The infectious disease diagnostics market share is expected to increase to USD 13.94 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.7%.

This infectious disease diagnostics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers infectious disease diagnostics market segmentation by end-user (hospitals and labs) and geography (North America, Europe, Asia, and Rest of World (ROW)). The infectious disease diagnostics market report also offers information on several market vendors, including Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc, and Vela Diagnostics among others.

What will the Infectious Disease Diagnostics Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Infectious Disease Diagnostics Market Size for the Forecast Period and Other Important Statistics

Infectious Disease Diagnostics Market: Key Drivers, Trends, and Challenges

The increasing prevalence of infectious diseases is notably driving the infectious disease diagnostics market growth, although factors such as the availability of counterfeit drugs in the developing economies may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the infectious disease diagnostics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Infectious Disease Diagnostics Market Driver

• One of the key factors driving the global infectious disease diagnostics market growth is the increasing prevalence of infectious diseases.
• The outbreaks of infectious diseases have increased due to changing lifestyles, which result in reduced immunity.
• The pattern of infection incidence has also been changing with the evolution of drug-resistant pathogens.
• As per the Joint United Nations Programme on HIV/AIDS data of 2020, 680,000 people died from AIDS-related illnesses across the world.
• The prevalence of meningococcal disease, which is caused by the bacterium Neisseria, meningitides, was decreased, owing to the meningococcal vaccines, which were licensed and made available in August 2020 in the US.
• According to the CDC data for 2021, annually, almost 4,100 cases and 500 deaths occur due to meningococcal disease in the US.
• The rise in the prevalence of infectious diseases is expected to drive the growth of the market in focus during the forecast period.

Key Infectious Disease Diagnostics Market Trend

• Increase in M&A is one of the key infectious disease diagnostics market trends that is expected to impact the industry positively in the forecast period.
• The vendors operating in the market are focusing on pursuing inorganic growth to tap into rapidly growing markets, such as India, Brazil, China, and South Africa.
• In August 2021, Sanofi S.A acquired Translate Bio Inc., a clinical-stage mRNA therapeutics company, for over $3 billion.
• In April 2021, Pfizer Inc. acquired Amplyx Pharmaceuticals Inc., an American pharmaceutical company, with an aim to access the Fosmanogepix (APX001).
• In May 2020, Novavax Inc., a biotechnology company specializing in next-generation vaccines, spent over $160 million and acquired Praha Vaccines A.S.
• A rise in M&A activities across the globe is anticipated to boost the growth of the market in the forecast years.

Key Infectious Disease Diagnostics Market Challenge

• One of the key challenges to the global infectious disease diagnostics market growth is the availability of counterfeit drugs in developing economies.
• The counterfeit products pose a challenge for the global pharmaceutical manufacturers, costing them billions of dollars and negatively affecting their brand reputation.
• Counterfeit drugs provide a false sense of security to the patients using them while endangering them even more with the contents of the products.
• The counterfeits are widely available in low-income and developing countries because of insufficient regulations and manufacturing control.
• The fear of stigma often makes HIV patients buy antiretrovirals through unauthorized retailers.
• Due to the increase in the prevalence of AIDS in underdeveloped countries, such as India, Brazil, and Iran, counterfeiters may gain profits from the counterfeiting of antiretroviral drugs without easily being noticed.
• The wide availability of counterfeit drugs may hamper the growth of the market in focus during the forecast period.

This infectious disease diagnostics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global infectious disease diagnostics market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the infectious disease diagnostics market during the forecast period.

Who are the Major Infectious Disease Diagnostics Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Abbott Laboratories
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• bioMerieux SA
• Danaher Corp.
• DiaSorin SpA
• F. Hoffmann La Roche Ltd.
• Genetic Signatures Ltd.
• Grifols SA
• Hologic Inc.
• Meridian Bioscience Inc.
• Meril Life Sciences Pvt. Ltd.
• OraSure Technologies Inc.
• PerkinElmer Inc.
• QIAGEN NV
• Siemens AG
• Sysmex Corp.
• Thermo Fisher Scientific Inc.
• Trinity Biotech Plc
• Vela Diagnostics

This statistical study of the infectious disease diagnostics market encompasses successful business strategies deployed by the key vendors. The infectious disease diagnostics market is fragmented and the vendors are deploying growth strategies such as investment in research and development to compete in the market.

Product Insights and News

• Abbott Laboratories - Under the established pharmaceuticals products segment, the company focuses on core laboratory, molecular solutions, point of care solutions, and rapid diagnostics.
• Becton Dickinson and Co. - The BD Medical segment offers a range of medication delivery solutions, medication management solutions, diabetes care, and pharmaceutical systems.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The infectious disease diagnostics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Infectious Disease Diagnostics Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the infectious disease diagnostics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Infectious Disease Diagnostics Market?

For more insights on the market share of various regions Request for a FREE sample now!

37% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for infectious disease diagnostics in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

The increase in the prevalence of infectious diseases, such as AIDS, TB, meningitis, influenza, and pneumonia will facilitate the infectious disease diagnostics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the outbreak of COVID-19 affected the economies of all countries in North America, especially the US. However, the pandemic had a mixed impact on the regional infectious disease diagnostics market. The rise in the number of COVID-19 cases in the first quarter of 2020 led to partial lockdowns in several countries, including Canada and Mexico. Most of the pharmaceutical operations were directed toward developing vaccines and therapeutics for COVID-19, which fostered the growth of the regional infectious disease diagnostics market in 2020 and mid-2021 to a substantial extent. For instance, in December 2020, the US FDA authorized the COVID-19 mRNA vaccine, developed by Pfizer Inc. and BioNTech SE, for emergency use in the US. Thus, the rising prevalence of infectious diseases in the region will drive the growth of the regional infectious disease diagnostics market during the forecast period.

What are the Revenue-generating End-user Segments in the Infectious Disease Diagnostics Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The infectious disease diagnostics market share growth by the hospital segment will be significant during the forecast period. The growth is attributed to the increase in the number of patients suffering from different types of diseases, such as AIDS, tuberculosis (TB) meningitis, and COVID-19, globally. The growing presence of the large-, medium-, and small-sized hospitals that procure medical products, including infectious disease diagnostic instruments, in bulk from suppliers and group purchasing organizations (GPOs) will further boost the market growth. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the infectious disease diagnostics market size and actionable market insights on post COVID-19 impact on each segment.

Request for a FREE sample

What are the Key Data Covered in this Infectious Disease Diagnostics Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive infectious disease diagnostics market growth during the next five years
• Precise estimation of the infectious disease diagnostics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the infectious disease diagnostics industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of infectious disease diagnostics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch